financetom
Business
financetom
/
Business
/
Measures by Colombia stock exchange may allow it to stay in JPMorgan index -president
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Measures by Colombia stock exchange may allow it to stay in JPMorgan index -president
Apr 29, 2024 7:19 AM

BOGOTA, April 29 (Reuters) - Measures adopted by the

Colombian stock exchange and securities issuers to improve

liquidity could be enough for the country to hold onto its

"emerging market" classification and stay in a key JPMorgan ( JPM )

index, but more progress is needed, the stock exchange's

president said.

Last year JPMorgan ( JPM ) warned Colombia could be excluded from

its MSCI emerging markets index and be downgraded to a frontier

market due to declining liquidity.

The warning sparked a sharp drop in share prices across the

stock exchange as a downgrade would drive away foreign investors

guided by the bank's indexes.

Just three Colombian stocks are included in JPMorgan's ( JPM ) MSCI

index; Bancolombia, Bancolombia Preferential and energy

conglomerate ISA.

The stock exchange has cut costs for issuing new shares,

while companies have hired liquidity providers to promote them,

among other measures, in a combined effort to boost liquidity,

Colombian stock exchange chief executive Andres Restrepo said.

"From our figures, we don't think the downgrade risk will

materialize," Restrepo told Reuters late on Friday. "The

performance of the three stocks that form part of the MSCI

Emerging index has recovered."

In March, Davivienda, Colombia's third-largest bank, carried

out a share issue for $183.4 million, while Spanish bank BBVA's

Colombian unit said in mid-April that it was preparing a share

issue worth 220 million euros.

The next step will be to promote including other companies

into JPMorgan's ( JPM ) MSCI emerging markets index, which will require

more share issues, said Restrepo, who has held the job since

February.

Cementos Argos could be a candidate following a

decision to convert its preferential shares into common shares,

Restrepo said, adding that Colombia's majority state-owned oil

company Ecopetrol could return to the index after it

was pushed out at the end of 2022.

"Ecopetrol could very quickly enter the index with a

decision I understand is no small thing, but which is to

increase its float by selling no more than 3% (of its shares),"

Restrepo said.

Currently, 11.5% of Ecopetrol's shares are traded on the

stock market, while 88.5% is owned by the Colombian state.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Johnson Controls Stock Is Up Monday
Why Johnson Controls Stock Is Up Monday
May 20, 2024
Johnson Controls International ( JCI ) shares are trading higher Monday following reports that Elliott Investment Management acquired a large stake in the company. The Details: Activist investor Elliott Investment has amassed a position in Johnson Controls ( JCI ) valued at over $1 billion, according to Bloomberg. The report indicates that Elliott Investment is now one of the top...
Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants
Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants
May 20, 2024
11:14 AM EDT, 05/20/2024 (MT Newswires) -- Foghorn Therapeutics ( FHTX ) said Monday it priced a registered direct offering of 12.7 million shares at $5.51 each, along with pre-funded warrants to buy up to 7.2 million shares at $5.5099 apiece in lieu of stock to certain investors, for gross proceeds of $110 million. The offering is expected to close...
Lisata Therapeutics Receives European Medicines Agency Pediatric Waiver for Pancreatic Cancer Treatment
Lisata Therapeutics Receives European Medicines Agency Pediatric Waiver for Pancreatic Cancer Treatment
May 20, 2024
11:14 AM EDT, 05/20/2024 (MT Newswires) -- Lisata Therapeutics ( LSTA ) said Monday it has obtained a full pediatric waiver from the European Medicines Agency for investigational drug certepetide in pancreatic cancer. The agency granted the waiver based on the recommendation of its pediatric committee, which cited that pancreatic cancer occurs exclusively in adults, the company said. The waiver...
Immunome Completes Purchase of Antibodies From Atreca
Immunome Completes Purchase of Antibodies From Atreca
May 20, 2024
11:14 AM EDT, 05/20/2024 (MT Newswires) -- Immunome ( IMNM ) said Monday it completed its purchase of antibodies and related assets from Atreca for an upfront payment of $5.5 million and a potential clinical development milestone payment of up to $7 million. Shares of the company fell 0.5% in recent trading. Price: 13.76, Change: -0.07, Percent Change: -0.51 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved